The precise personal management is expected to glaucoma neuroprotection

Authors: Ge Jian

DOI: 10.3760/cma.j.issn.2095-0160.2017.04.001
Published 2017-04-10
Cite as Chin J Exp Ophthalmol, 2017,35(4): 289-292.

Abstract

Glaucoma is a common blinding eye disease mainly characterized by optic nerve damage.Lowing intraocular pressure is still the main managing method of glaucoma up to now.However, although the intraocular pressure is reasonably controlled, optic nerve damage is difficult to recovery and sustainable development in some patients.Therefore, the pathogenesis and prevention and treatment of glaucoma have always been the hot spot of the research of glaucoma in recent years.Even though the big progresses have been made in the experimental research of optical nerve injury and repair, little good evidence has been seen in the clinical management of glaucoma neuroprotection.In recent years, genomics study, stem cells study, molecular biological study, electronic technology application in medical research, especially the rise of big data era laid a good basis for the neuroprotection of glaucoma.Ophthalmologists should focus on new insights into the potential and beyond impact factors in the precise individual therapy of glaucoma neuroprotection.

Key words:

Glaucoma; Neuroprotection; Precise individual therapy; Big data era

Contributor Information

Ge Jian
Zhongshan Ophthalmic Center, Sun Yat-sen University, State Key Laboratory of Ophthalmology, Guangzhou 510060, China
(Read 73 times, 1 visits today)
Updated: September 4, 2019 — 12:48 pm